Hemasri Velmurugan

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 12

Top Topics

Emergency Department

Transcranial Magnetic Stimulation

Acinetobacter Baumannii

Top Venues

Infectious disorders drug targets

Current drug safety

Current medicinal chemistry

Current diabetes reviews

This page only lists publications with an associated author ORCID identifier.

Publications

Hemasri Velmurugan, Sajitha Venkatesan, Hadush Negash Meles, Krishnapriya Neelambaram, Pugazhenthan Thangaraju
Sulbactam-Durlobactam, A Novel Drug for the Treatment of Multidrug Resistant Acinetobacter baumannii Infections - A Systematic Review. Infectious disorders drug targets 24 (6) (2024)
Sadasivam Nehru, Pugazhenthan Thangaraju, Nehru Cibee, Hemasri Velmurugan
Dog Bite Injury: Rusk Became a Risk - A Case Report. Infectious disorders drug targets (2024)
Krishnapriya Neelambaran, Hemasri Velmurugan, Sajitha Venkatesan, Pugazhenthan Thangaraju
Ralstonia mannitolilytica Infections: A Systematic Review of Case Reports Unveiling Clinical Patterns and Therapeutic Insights. Current drug research reviews (2024)
Hemasri Velmurugan, Sajitha Venkatesan, Hadush Negash Meles, Pugazhenthan Thangaraju, Krishnapriya Neelambaram
Sulbactam-Durlobactam, A Novel Drug for the Treatment of Multidrug-resistant Acinetobacter baumannii Infections - A Systematic Review. Infectious disorders drug targets (2024)
Raja Narendra Divakar Addanki, Anjali Srikanth Mannava, Hemasri Velmurugan, Pugazhenthan Thangaraju
Treatment Modalities for Trigeminal Neuralgia and the Need for Vigilance in Monitoring Adverse Drug Events: A Case Report. Current drug safety (2024)
Sadasivam Nehru, Pugazhenthan Thangaraju, Nehru Cibee, Hemasri Velmurugan
Dog Bite Injury: Rusk Became a Risk - A Case Report. Infectious disorders drug targets 24 (6) (2024)
Hemasri Velmurugan, Anjali Srikanth Mannava, Pugazhenthan Thangaraju, Krishnapriya Neelambaran
Kisspeptin and its Current Clinical Status- A Systematic Review. Current medicinal chemistry (2024)
Hemasri Velmurugan, Sajitha Venkatesan, Hadush Negash Meles, Krishnapriya Neelambaram, Pugazhenthan Thangaraju
Sulbactam-Durlobactam, A Novel Drug for the Treatment of Multidrug Resistant Acinetobacter baumannii Infections - A Systematic Review. Infectious disorders drug targets 24 (6) (2024)
Hemasri Velmurugan, Krishnapriya Neelambaran, Meenalotchini Prakash Gurunthalingam, Dushyant Chouhan, Pugazhenthan Thangaraju, Bikram Keshari Kar, Nitin Rewaram Gaikwad
Vigilance Needed in Treating a Child with Disseminated TB: A Case Report. Infectious disorders drug targets (2024)
Raja Narendra Divakar Addanki, Anjali Srikanth Mannava, Hemasri Velmurugan, Pugazhenthan Thangaraju
Treatment Modalities for Trigeminal Neuralgia and the Need for Vigilance in Monitoring Adverse Drug Events: A Case Report. Current drug safety 19 (4) (2024)
Pugazhenthan Thangaraju, Himanshu Nirmal Chandu, Hemasri Velmurugan, Pankaj Kumar Kannauje, R Arun Kumar
Analysis of Research Publications on Pharmacogenomics of Sulphonylurea - A Scientometric Study. Current diabetes reviews (2023)
Hemasri Velmurugan, Pugazhenthan Thangaraju
Nutritional Status in Leprosy Patients: A Systematic Review and Metaanalysis. Infectious disorders drug targets (2023)